sMicroRNA-28-5p acts as a metastasis suppressor in gastric cancer by targeting Nrf2

Cai-Feng Yue1, Lai-Sheng Li2, Lu Ai2

  • 1Department of Laboratory Medicine, Central People's Hospital of Zhanjiang, Guangdong Medical University Zhanjiang Central Hospital, Zhanjiang, 524045, PR China.

Insights

MicroRNA-28-5p acts as a tumor suppressor in gastric cancer by inhibiting Nrf2 expression, reducing cell migration and invasion. This finding suggests miR-28-5p as a potential biomarker and therapeutic target for gastric cancer.

Area of Science:

  • Molecular Oncology
  • Cancer Biology
  • Gene Regulation

Background:

  • Nuclear factor (erythroid-2)-related factor 2 (Nrf2) promotes cancer cell survival and is upregulated in gastric cancer (GC).
  • MicroRNA-28 (miR-28) regulates Nrf2 in breast cells, but its role in GC is uncharacterized.

Purpose of the Study:

  • To investigate the interaction between miR-28-5p and Nrf2 in gastric cancer.
  • To elucidate their roles in GC cell migration, invasion, and metastasis.

Main Methods:

  • Analysis of Nrf2 expression in GC tissues (n=42) via immunohistochemistry, RT-qPCR, and Western blot.
  • Bioinformatics analysis and dual luciferase reporter assay to confirm miR-28-5p targeting of Nrf2.
  • Gain- and loss-of-function studies to assess effects on GC cell behavior and epithelial-mesenchymal transition (EMT) markers.

Main Results:

  • Nrf2 was significantly upregulated in GC tissues, correlating with poor prognosis.
  • miR-28-5p directly targets and downregulates Nrf2 expression.
  • Overexpression of miR-28-5p or Nrf2 knockdown reduced GC cell migration, invasion, and N-cadherin expression while increasing E-cadherin.
  • miR-28-5p inhibited GC cell metastasis and tumorigenicity.

Conclusions:

  • miR-28-5p functions as a tumor suppressor in GC by inhibiting Nrf2.
  • miR-28-5p represses GC cell migration and invasion, potentially via regulating EMT.
  • miR-28-5p shows promise as a prognostic biomarker and therapeutic target for advanced GC.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.4K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
22.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.3K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.4K